PX7 — Human Optimization Infrastructure
Compound library
metabolic · fda-approved

Semaglutide

Análogo GLP-1 de longa ação aprovado por FDA.

Half-life
168 h
Routes
SC, oral
Typical dose
250–2400 mcg

Mechanism of action

Agonista de receptor GLP-1, modula glicemia e saciedade.

Reported applications

  • · glycemic control
  • · weight management

Frequently asked

What is Semaglutide?
Análogo GLP-1 de longa ação aprovado por FDA.
What is the half-life of Semaglutide?
Reference half-life: approximately 168 hours. Individual pharmacokinetics may vary.
Is PX7 prescribing Semaglutide?
No. PX7 is an educational reference and a community knowledge layer. It does not prescribe, sell, or recommend substances.

Explore the cluster

PX7 publishes educational and community-curated references on regenerative and longevity science. Nothing on this page is medical advice, prescription, or a recommendation to obtain or use any substance. Always consult a qualified clinician.